What is expected of a medical director in the Centers for Medicare and Medicaid Services Conditions of Coverage?
نویسنده
چکیده
The Medicare Conditions for Coverage for dialysis facilities, effective since 2008, make the medical director responsible for all levels of quality patient care in the facility. This includes issues such as water quality, infection control, staff education, policy/procedure development and implementation, dialyzer reuse, involuntary discharges, and patient safety. Most importantly, the medical director is the leader of the team responsible for quality assessment and performance improvement, which is central to the process of continuous quality improvement in the dialysis facility and the basis for much of Medicare's evaluation of facility performance. Through the measures assessment tool, the Conditions for Coverage specify the required domains for quality improvement activities in the dialysis facility, including dialysis adequacy, nutrition, bone disease, anemia management, vascular access, medical errors, patient satisfaction, and infection control. Under the leadership of the medical director, the quality assessment and performance improvement team identifies opportunities for improvement, tests and implements interventions, collects data, interprets results, and links system change with improved outcomes. These activities are rigorously documented and provide evidence to Medicare that the facility is acting responsibly to provide the best possible services for which it is being paid. The medical director is fairly compensated for his/her services by the facility, but must always act in the patients' best interest when evaluating policy changes directed at cost containment. The success of a medical director in shepherding positive change in a dialysis facility can be immensely satisfying as it impacts on patients other than his/her own.
منابع مشابه
What Medical Directors Need to Know about Dialysis Facility Water Management.
The medical directors of dialysis facilities have many operational clinic responsibilities, which on first glance, may seem outside the realm of excellence in patient care. However, a smoothly running clinic is integral to positive patient outcomes. Of the conditions for coverage outlined by the Centers for Medicare and Medicaid Services, one most critical to quality dialysis treatment is the p...
متن کاملF-tag 501 medical director: where are we now?
It has been almost 4 years since the revised F-tag 501 medical director was released by the Centers for Medicare and Medicaid Services (CMS). There was much consternation at that time regarding the impact it would have on the future of long-term care and medical director–facility relationship. Much has been written on what the medical director should be doing given the new regulations. The ques...
متن کاملReforming laboratory reimbursement: issues, impact and innovations. A summary of the clinical chemistry forum held on November 15, 2001.
The focus of the American Association for Clinical Chemistry’s 11th Clinical Chemistry Forum, held in Alexandria, VA, on November 15, 2001, was on current and future direction of Medicare reimbursement. Reimbursement issues involve coverage policies, particularly as they relate to new tests, and coding system changes, with the continued influence of the Office of the Inspector General (OIG) in ...
متن کاملMDS 3.0 section M: Skin Conditions: what the medical director needs to know.
The Centers for Medicare and Medicaid Services has released the new Resident Assessment Instrument version 3.0, which went into effect October 1, 2010. The intention of the revised Resident Assessment Instrument is to improve health-related quality of life and care planning, and incorporate evolving standards of terminology, assessment, and technology. To reach this goal, Section M: Skin Condit...
متن کاملHow changes in the Medicare coverage process have facilitated the spread of new technologies.
The Medicare coverage decision process can affect the availability and use of new technologies. The Centers for Medicare and Medicaid Services (CMS) has recently made advances in making its coverage decision process speedier, predictable, and more transparent. The CMS recently issued draft Coverage with Evidence Development (CED) guidance to assure that Medicare beneficiaries have access to new...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Blood purification
دوره 31 1-3 شماره
صفحات -
تاریخ انتشار 2011